Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
PDS Biotechnology Corporation (PDSB) had Debt to Capital Ratio of 0.45 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.43M |
|
-- |
|
-- |
|
$7.62M |
|
$-7.62M |
|
$-1.81M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-9.43M |
|
$-7.62M |
|
$-6.49M |
|
45.90M |
|
45.90M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$33.65M |
|
$0.13M |
|
$6.83M |
|
$40.48M |
|
$11.53M |
|
$12.98M |
|
$12.98M |
|
$24.52M |
|
$15.96M |
|
$15.96M |
|
$15.96M |
|
46.63M |
|
| Cash Flow Statement Financials | |
$-18.13M |
|
-- |
|
$8.32M |
|
$41.69M |
|
$31.87M |
|
$-9.82M |
|
$1.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.45 |
1.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.11% |
|
-59.11% |
|
-23.31% |
|
-32.59% |
|
$0.34 |
|
$-0.40 |
|
$-0.40 |
|